Retaglutide is a novel GLP-1 receptor agonist currently under investigation for the control of metabolic disorders. This medication works by mimicking the effects of glucagon-like peptide-1 (GLP-1), a naturally https://zoeehub824548.blogdosaga.com/38956075/semaglutide-a-potential-solution-for-obesity